Journal
Cancer Medicine
Publication Date
2019
Volume
8
Issue
6
Inclusive Pages
2994-3003
Document Type
Open Access Publication
DOI
10.1002/cam4.2136
Rights and Permissions
Van Tine, BA, Agulnik, M, Olson, RD, et al. A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma. Cancer Med. 2019; 8: 2994– 3003. https://doi.org/10.1002/cam4.2136 © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Van Tine, Brian A.; Agulnik, Mark; Olson, Richard D.; Walsh, Gerald M.; Klausner, Arthur; Frank, Nicole E.; Talley, Todd T.; and Milhem, Mohammed M., "A phase II clinical study of 13-deoxy, 5-iminodoxorubicin (GPX-150) with metastatic and unresectable soft tissue sarcoma." Cancer Medicine. 8, 6. 2994-3003. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/7942
